Travel & financial grants

This page describes a copay assistance program for Promacta (eltrombopag) medication, facilitated by QuickRx Specialty Pharmacy, to help patients reduce out-of-pocket drug costs through manufacturer cards, foundation grants, and patient assistance programs. It is not a travel assistance grant.

Novartis and various foundations

This program offers financial assistance for Promacta (eltrombopag) medication, aiming to significantly reduce patients' out-of-pocket costs. QuickRx helps commercially insured patients enroll in manufacturer copay card programs and assists Medicare, Medicaid, and uninsured patients in accessing foundation grants and patient assistance programs. The goal is to eliminate financial barriers to treatment for conditions like ITP, aplastic anemia, or hepatitis C.

This page describes various copay assistance programs for Promacta (eltrombopag) medication to help reduce out-of-pocket costs for patients with ITP or aplastic anemia. It does not provide information about travel assistance grants.

PAN Foundation

The PAN Foundation Transportation Fund offered $500 grants to help patients cover various travel expenses. These grants could be used for gas, parking, public transportation, taxis, and airfare. The fund is currently closed and not accepting applications.

PAN Foundation

The PAN Foundation Transportation Fund offered $500 transportation grants to use for gas, parking, public transportation, taxis, and airfare. The fund is currently closed for applications.

PAN Foundation

This PAN Foundation grant assists patients with Pulmonary Hypertension by covering medication copays. Additionally, it offers financial support for transportation-related expenses. Applicants must verify their income to determine eligibility.

PAN Foundation

This grant, offered by the PAN Foundation, provides financial assistance for out-of-pocket medication copay costs for patients with pulmonary hypertension. Specific eligibility criteria regarding income are not detailed in the provided content.

Puma Biotechnology

Puma Patient Lynx provides various support programs for US residents with HER2+ breast cancer who are considering or prescribed NERLYNX. These programs focus on making NERLYNX accessible through financial assistance (for the drug itself and co-pays), a quick start supply, and vouchers for antidiarrheal medication to manage side effects. A confidential mentor program is also available for peer support, but no travel assistance is mentioned.

QuickRx Specialty Pharmacy

This program by QuickRx Specialty Pharmacy offers free services to help prostate cancer patients manage the high cost of Zytiga (abiraterone acetate) or generic abiraterone treatment. It assists patients in applying for manufacturer copay cards, enrolling in patient assistance programs, and coordinating foundation grants to reduce medication out-of-pocket expenses. QuickRx's direct assistance services are free to all patients seeking financial support for their medication.

QuickRx Specialty Pharmacy

QuickRx Specialty Pharmacy offers assistance to reduce out-of-pocket costs for treprostinil medications (e.g., Remodulin, Tyvaso) for patients with pulmonary arterial hypertension (PAH). This includes connecting eligible patients to manufacturer copay cards, patient assistance programs, and foundation grants. Eligibility depends on insurance type, the specific medication, and for uninsured patients, financial need.

Geron Corporation

The REACH4RYTELO Patient Support Program assists patients prescribed RYTELO (for MDS) with navigating medication access and reimbursement, including benefits investigation, prior authorization, and appeals support. It also offers a copay program for the medication itself. The program does not explicitly mention covering travel expenses.

Recordati Rare Diseases

The Recordati Rare Diseases Patient Liaison Support program offers a Patient Liaison (PL) at no cost to eligible patients and their caregivers to help manage CYSTADROPS treatment. This program provides support services related to medication management rather than financial assistance for travel, lodging, or gas.

PAN Foundation

The PAN Foundation offers a grant to assist patients with Rett syndrome. While named a 'copay grant,' it provides financial aid for medical expenses and generally includes coverage for transportation purchases. Specific travel categories like flights or hotels, and detailed eligibility beyond general PAN guidelines, are not explicitly provided in the available content for this fund.

PAN Foundation

The Rheumatoid arthritis copay grant from the PAN Foundation helps patients with the costs of their treatment copays for rheumatoid arthritis. It may also cover transportation purchases, as listed under general grant coverage. Eligibility typically requires income verification, though specific financial requirements are not detailed here.

PAN Foundation

This grant from the PAN Foundation provides assistance for transportation purchases, and is intended for eligible patients with Rheumatoid arthritis to help cover copayments. Applicants must meet unspecified eligibility criteria, which includes verifying income or insurance premium.

PAN Foundation

This grant from the PAN Foundation offers assistance for transportation purchases. Patients must have an income up to 400% of the Federal Poverty Level to qualify.

Rigel Pharmaceuticals

The Rigel ONEcare Patient Support Program primarily offers financial and copay assistance for patients with commercial insurance prescribed REZLIDHIA. The provided page content does not indicate that this is a travel assistance grant or that it covers travel-related expenses.

Genentech USA, Inc.

RITUXAN HYCELA Access Solutions helps patients understand their insurance coverage and find assistance options to obtain RITUXAN HYCELA medication. The page does not provide any details regarding travel assistance, such as coverage for flights, hotel, or gas, nor does it specify any income requirements for financial aid related to the medication.

PAN Foundation

This grant, provided by the PAN Foundation, offers financial assistance to patients with Short Bowel Syndrome (SBS) to help cover their medication copay costs. This specific grant is identified as medication copay assistance and does not explicitly state coverage for travel expenses on its dedicated page.

The Assistance Fund

The Sickle Cell Disease Financial Assistance Program, provided by The Assistance Fund, offers financial assistance for out-of-pocket costs such as prescription drugs, health insurance premiums, therapy administration costs, genetic testing, and ground travel to a treatment center. To qualify, patients must be a U.S. citizen or permanent resident, diagnosed with sickle cell disease, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting requests to join its enrollment waitlist.

PAN Foundation

The PAN Foundation offers a copay grant for patients with small cell lung cancer. Applicants must verify their income or insurance premium to determine eligibility for assistance with treatment copayments.

PAN Foundation

Spondylitis Association of America

This page serves as a directory of patient assistance programs from various pharmaceutical companies, specifically aimed at helping individuals with spondyloarthritis manage prescription medication costs, co-pays, and other healthcare expenses. Eligibility criteria, often tied to financial need and insurance status, are determined by each individual program. This resource does not provide direct financial grants for travel assistance.

SpringWorks Therapeutics

SpringWorks CareConnections is a free, personalized patient support program offered by SpringWorks Therapeutics for individuals prescribed OGSIVEO™. It assists patients with insurance navigation, treatment questions, and adherence to medication. The program content does not explicitly mention coverage for travel expenses.

Bristol Myers-Squibb

The Sprycel One Card is a co-pay assistance program offered by Bristol Myers-Squibb for commercially insured patients aged 18 and over who are prescribed Dasatinib (Sprycel). This program helps cover the cost of medication co-payments, rather than travel expenses.

Bayer

This program provides up to $25,000 in annual co-pay assistance for the prescription drug STIVARGA, covering out-of-pocket costs. It is available to eligible commercially insured US residents over 18 who are not enrolled in federal or state subsidized healthcare programs.